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Active screening for diabetes 
mellitus: data from 88 oral glucose 
tolerance tests with 75 g of glucose 
performed in patients in general 
practice in urban area based on 
previous 250 fasting plasma glucose 
determinations
Aktywne badania przesiewowe w celu wykrycia 
cukrzycy: dane z 88 OGTT 75 g wykonanych 
u pacjentów w miejskiej praktyce lekarza rodzinnego 
na podstawie wcześniejszych 250 oznaczeń poziomu 
glukozy na czczo
ABSTRACT
Background: Diabetes mellitus (DM) and other glucose metabolism abnormalities are one 
of biggest challenges for the public health in the 21st century. 
Objectives: In general practice efforts should be made to early detect glucose metabolism 
abnormalities, which allows for fast diagnosis of medical problem in individual patients 
and implementation of lifestyle modification and/or pharmacological treatment. 
Material and methods: The present study is based on cross-sectional data from 250 patients, 
a sample from the general practice “Ogrody” located in industrial area of Bydgoszcz, where 
biochemical analyses were conducted in second half of 2014. Each patient with fasting 
plasma glucose ≥ 100 mg/dl who hasn’t been previously diagnosed with type 2 diabetes 
mellitus was referred for “gold standard” 75 g oral glucose tolerance test (OGTT). 
Results: According to study design, 75 g OGTT was performed in 88 patients with elevated 
fasting plasma glucose after excluding individuals with previously diagnosed diabetes 
mellitus. 
Conclusions: 1) Among 250 primary care patients, 176 (70,40%) had fasting plasma glu-
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BACKGROUND
Nowadays one of biggest challenges for family 
medicine is improving the quality and length 
of life. One of ways to do this is to actively 
influence the so-called civilization diseases 
through early diagnosis of medical problem 
in individual patients, modification of lifestyle 
and implementation of appropriate pharma-
cological treatment. As the human life span 
increases, its quality is gradually reduced and 
the morbidity and mortality related to cardio-
vascular diseases rapidly increases. One of 
the main causes is the increase in the num-
ber of different carbohydrate metabolism 
disorders which, if not monitored, quickly 
lead to the development of diabetes mellitus 
(DM) and cardiovascular diseases (CVD) 
[1–4]. Nowadays, many investigators observe 
a rapid increase in various abnormalities of 
glucose metabolism among general practice 
patients [5–7]. It is very important for the me-
dical professionals to focus a special effort on 
cose ≥ 100 mg/dl. 2) On the basis of a gold standard test, 75 g OGTT, following glucose 
metabolism disturbances were diagnosed (in order of frequency; number and %): IFG 
39 (37,50%); IFG+IGT 22 (25,00%); T2DM 16 (18,18%); normal result of OGTT 11 (12,50%) 
and IGT 6 (6,82%). 3) In general practice, emphasis on detection of glucose metabolism 
abnormalities allow for early diagnosis of medical problem in individual patients and im-
plementation of lifestyle modification and/or pharmacological treatment.
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STRESZCZENIE
Wstęp: Cukrzyca typu 2 i inne zaburzania gospodarki węglowodanowej są jednym z głównych 
wyzwań dla zdrowia publicznego na przełomie XX–XXI wieku. 
Cel badania: W praktyce lekarza ogólnego położenie szczególnego nacisku na szybką diag-
nostykę nieprawidłowości gospodarki węglowodanowej, która pozwala na postawienie 
rozpoznania u pacjenta, modyfikację stylu życia i wdrożenie leczenia farmakologicznego. 
Materiał i metody: W 2014 roku u 250 osób z praktyki lekarza rodzinnego (NZOZ “Ogrody” 
w mieście przemysłowym) wykonano przekrojowe oznaczenia laboratoryjne. Każdej osobie 
z glikemią na czczo ≥ 100 mg /dl i bez wcześniej rozpoznanej cukrzycy wykonano następnie 
OGTT 75 g jako „złoty standard” w rozpoznawaniu zaburzeń gospodarki węglowodanowej. 
Wyniki: Łączne wykonano 88 OGTT u osób z nieprawidłową glikemią na czczo w badaniu 
przesiewowym, które nie miały uprzednio postawionego rozpoznania cukrzycy. 
Wnioski: 1) W praktyce lekarza rodzinnego176 (70,40%) osób z 250 miało poziom glukozy na 
czczo ≥ 100 mg /dl. 2) Zgodnie ze „złoty standardem” OGTT postawiono następujące rozpo-
znania (w porządku według częstości; liczba i %): IFG 39 (37,50%); IFG+IGT 22 (25,00%); 
DM t2 16 (18,18%); normoglikemia wg OGTT 11 (12,50%) i IGT 6 (6,82%). 3) W praktyce 
lekarza ogólnego położenie nacisku na rozpoznawanie zaburzeń gospodarki węglowoda-
nowej pozwala na szybkie postawienie rozpoznania medycznego problemu u pacjenta, 
modyfikację jego stylu życia oraz wdrożenie adekwatnego leczenia farmakologicznego.
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prevention in patients who have not develo-
ped DM and/or CVD yet — this is the best 
way to reduce high socioeconomic cost [8–10].
OBJECTIVES
In general practice efforts should be made to 
early detect glucose metabolism abnormali-
ties, which allows for fast diagnosis of medical 
problem in individual patients and implemen-
tation of lifestyle modification and/or phar-
macological treatment.
The primary objective of this study is to 
answer the following questions:
1) How often do patients in my GP practice 
have abnormal fasting plasma glucose le-
vels?
2) What types of carbohydrate disorder oc-
cur in these patients (excluding patients 
with previously diagnosed DM)?
3) Are there other abnormalities (in blood 
morphology and/or biochemical parame-
ters) in patients who underwent a gold 
standard test, i.e. 75 g OGTT?
MATERIAL AND METHODS
Study design
The present study is based on cross-sectional 
data from 250 patients — a sample from the 
general practice “Ogrody” located in the in-
dustrial area of Bydgoszcz, where biochemical 
analyses were conducted in the second half 
of 2014. The methodology of anthropome-
tric measurements (including height, weight, 
waist [WC] and hip circumferences [HC]) was 
similar to the one described previously [11]. 
Patients
Each patient with plasma glucose ≥ 100 mg/dl 
who hasn’t been previously diagnosed with 
type 2 diabetes mellitus was referred for “gold 
standard” 75 g oral glucose tolerance test.
Biochemical variables 
Samples of venous blood were taken follo-
wing a 12 h overnight fast from the antecubi-
tal vein with suitable vacutainers according 
to norm ISO 6710 and underwent standard 
biochemical analysis (venous blood morpho-
logy; ESR/Westergren ESR; ALAT; concen-
trations of total cholesterol, HDL and LDL 
cholesterol, triglycerides and glucose; potas-
sium and creatinine levels) in certificated la-
boratory “Vitalabo” in Bydgoszcz [12].
Classification of OGTT results
According to diagnostic criteria for DM [13], 
the patients who underwent screening for glu-
cose metabolism disturbances were divided 
into 5 subgroups on the basis of the results 
of 75 g OGTT: 
0 — normal OGTT,
1 — impaired fasting glucose (IFG),
2 — impaired glucose tolerance (IGT),
3 — IFG + IGT ,
4 — DM (de novo type 2 diabetes mellitus).
Statistical analyses
Based on primary measurement, BMI, 
WHR and estimated glomerular filtration 
rate (GFR) values were calculated using 
MDRD, Cockcroft-Gault or CKD-EPI formu-
las. Significance was accepted at p < 0,05. The 
results are shown in 2 figures and 4 tables. Sta-
tistical analysis was carried out using Statisti-
ca software StatSoft [14] under license from 
the Department of Biophysics, Faculty of 
Pharmacy CM UMK in Bydgoszcz. 
RESULTS
In 250 adult patients (130 females and 120 ma-
les) from general practice, fasting plasma 
glucose was measured. Figure 1 shows their 
age (mean 71,42 x ± 10,01 years, max. 92 and 
min. 38). The most numerous age group were 
people from 70 to 80 years. 
One hundred and seventy-six out of 250 pa-
tients had fasting plasma glucose ≥ 100 mg/dl. 
Among them, 63 patients (35,80%) had pre-
vious diagnosed type 2 diabetes mellitus. One 
hundred and fourteen patients were referred 
for oral 75 g oral glucose tolerance test. In 
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88 patients (77,19%), 75 g OGTT was perfor-
med by the end of 2014, but in 26 (22,81%) the 
test hadn’t been performed (unknown reason). 
The final analysis included only those patients 
(Figure 2) who underwent 75 g OGTT.
Eighty-eight adult patients (39 women 
and 49 men) from general practice under-
went OGTT. Figure 1 shows their age (mean 
72,62 ± 9,89 years; max. 92; min. 41). The 
most numerous age group were people from 
70 to 80 years, similarly as in the previously 
pre-screened group (250 patients).
On the basis of 75 g OGTT results the 
patients were divided into 5 subgroups: 
0 – normal OGTT; 1 — IFG; 2 — IGT; 
3 — IFG+IGT and 4 — DM (de novo type 
2 diabetes mellitus). 
In the practice of family physician, most 
patients (39 [37,50%]; 75,18 ± 7,51 years; 
17 women vs 16 men) had IFG followed by 
IFG+IGT (22 [25,00%]; 69,73 ± 12,73; 10 vs 
12). Diabetes mellitus was diagnosed in abo-
ut 1 in 5 patients (subgroup 4: 16 patients 
[18,18%]; 72,75 ± 10,31 years; 4 women vs 
12 men). Less common were normal result 
of OGTT (11 [12,50%]; 70,45 ± 10,52; 5 vs 
6) and IGT (6 [6,82%]; 72,83 ± 5,64; 3 vs 3).
Table 2 shows fasting plasma glucose 
(mg/dl; mean and SD) and glucose values at 
0 and 120 minutes of 75 g OGTT. This test 
enables identification of patients with normo-
glicaemia and those with IFG, IGT or DM.
Table 3 shows that patients with DM (sub-
group 4) are characterized by higher body 
Figure 1. Age (mean, SD, min., max.) of the 
patients included in the study and graphic 
presentation of age ditribution
Figure 2. Age (mean, SD, min., max.) of patients 
included in the final analysis and graphic 
presentation of age distribution
Table 2
Fasting plasma glucose (mean and SD) and glucose values at 0 and 120 minutes of 
OGTT
∑ — sum 0 — normal 1 — IFG 2 — IGT 3 — IFG+IGT 4 — DM 
Glucose 112,62±9,91 104,94±4,22 111,75±10,52 105,88±4,65 113,60±8,94 120,90±8,08
0 OGTT 110,46±13,27 92,67±7,14 111,15±9,23 93,03±5,55 115,65±9,70 120,67±12,55
2h OGTT 154,97±57,45 102,30±25,68 116,60±22,01 168±11,50 163,84±14,93 252,93±40,20
Table 1
Age and gender of patients according to the results of OGTT
∑ — sum 0 — normal 1 — IFG 2 — IGT 3 — IFG+IGT 4 — DM 
Number n (%) 88 (100%) 11 (12,50%) 33 (37,50%) 6 (6,82%) 22 (25,00%) 16 (18,18%)
Age (mean±SD) 72,62±9,89 70,45±10,52 75,18±7,51 72,83±5,64 69,73±12,73 72,75±10,31
0 – women 39 5 17 3 10 4





weight (84,19 ± 12,97 kg) then other subgro-
ups. They (subgroup 4) were also slightly hi-
gher (170,37 ± 8,55 cm then other subgroups, 
but had higher BMI (29,09 ± 4,08). However, 
small number of patients in the subgroups did-
n’t allow for the general conclusion, that DM 
patients have statistically significantly higher 
body weight than remaining subgroups. The-
refore, Table 2 presents only BMI values in 
each 5 subgroups. Similarly, subgroup 4 (with 
DM) and subgroup 3 (IFG + IGT), seem to 
be more obese based on WC and WHR, but 
due to additional stratification by gender, the 
subgroups were too small to provide statistical 
significance. 
Table 4 contains detailed laboratory test 
results in patients with normal and elevated 
fasting plasma glucose. All blood morphology 
parameters (WBC, RBC, HGB, HCT, PLT) 
were similar in all 5 subgroups according to 
OGTT results (normal glucose metabolism 
vs IFG vs IGT vs IFG + IGT vs DM). Eryth-
rocyte sedimentation rate (ESR) was slightly 
higher (18,00 ± 12,21) in normoglicaemic pa-
Table 3
Anthropometric data of patients who underwent OGTT
∑ — sum 0 — normal 1 — IFG 2 — IGT 3 — IFG+IGT 4 — DM 
Weight 78,56±14,31 78,64±15,84 77,97±16,05 74,00±7,48 76,55±12,94 84,19±12,97
Height 167,68±14,31 167,64±9,07 166,48±10,06 169,33±7,00 167,09±10,83 170,37±8,55
BMI 27,84±4,55 27,85±4,31 27,96±5,07 25,94±3,80 27,26±4,44 29,09±4,08
BMI <=20.00 3 1 2 0 0 0
BMI 20<x<=25 19 1 7 2 6 3
BMI 25<x<=30 39 6 13 3 10 7
BMI >30.00 27 3 11 1 6 6
WC 100,71±11,44 97,33±12,73 96,67±13,25 96,50±8,23 106,50±8,33 106,22±8,21
HC 106,33±7,24 104,67±8,83 105,67±7,33 105,00±8,08 107,75±7,96 108,22±5,14
WHR 0,95±0,08 0,93±0,07 0,91±0,10 0,92±0,06 0,99±0,05 0,98±0,06
Table 4
Detailed laboratory test results (mean ± SD) blood morphology, ESR, ALAT, K+, lipid profile and creatinine in 
subgroups divided based on OGTT results
∑ — sum 0 — normal 1 — IFG 2 — IGT 3 — IFG+IGT 4 — DM 
WBC 6,59±1,52 6,15±1,28 6,64±1,40 5,69±1,16 6,65±1,44 7,04±2,01
RBC 4,62±0,40 4,49±0,38 4,62±0,47 4,23±0,37 4,68±0,34 4,66±0,37
HGB 14,19±1,17 13,55±1,04 14,14±1,28 14,10±1,00 14,31±0,98 14,60±1,25
HCT 42,04±4,48 40,64±2,49 42,28±3,92 41,67±2,81 42,76±2,74 41,69±7,99
PLT 241,6857,85 226,18±49,63 247±44,32 191,17±41,03 253,69±61,50 242,75±78,97
ESR 12,86±8,63 18,00±12,21 13,73±9,56 10,83±4,50 11,59±6,99 10,06±5,42
ALAT 21,53±8,52 21,05±8,07 19,42±6,57 21,83±6,56 23,10±9,24 23,98±11,46
Total cholesterol 204,34±42,37 221,62±31,49 207,41±47,72 202,23±37,41 195,69±40,97 198,83±41,15
HDL 54,14±12,51 58,19±14,70 56,93±13,28 48,17±15,34 52,25±8,86 51,93±12,08
LDL 123,26±37,21 133,25±28,03 125,91±42,38 125,05±26,59 117,10±36,69 118,77±37,27
TG 153,82±95,40 185,90±194,18 131,13±54,52 142,18±110,78 164,69±79,11 167,98±78,27
Creatinine 0,93±0,22 0,86±0,17 0,94±0,24 0,88±0,20 0,96±0,24 0,95±0,22
MDRD 79,30±20,05 85,66±20,20 76,28±18,39 80,60±13,01 77,76±21,51 82,75±23,84
Cockr 77,88±27,32 84,17±40,33 73,21±21,86 74,40±13,69 78,85±32,26 83,18±24,34
CKD_EPI 73,96±16,84 79,90±16,27 70,99±15,02 73,48±11,67 74,36±20,85 74,49±16,85
K+ 4,45±0,50 4,40±0,30 4,37±0,53 4,19±0,35 4,53±0,53 4,63±0,55
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tients than in other subgroups. It can explain 
two facts: increased sugar level simultaneous 
exceed viscousity solutio so them sedimenta-
tion rate of blood cells go down. Co-reason is 
that the more age of each people, the faster 
is falling erythrocytes what was find in large 
cohort healthy Norwegian adults [15]. In my 
study normoglicemic people were a little ol-
der then people with each type of glycemic 
abnormalities. All the other (mean and SD) 
laboratory test results (ALAT, total chole-
sterol, HDL, LDL, triglycerides, potassium 
and creatinine) and estimated glomerular fil-
tration rate (GFR) calculated using MDRD, 
Cockcroft-Gault or CKD-EPI formulas were 
in normal range.
CONCLUSIONS
1. Among 250 primary care patients, 
176 (70,40%) had fasting plasma glucose 
≥ 100 mg/dl. 
2. On the basis of a gold standard test, 
75 g OGTT, following glucose metabo-
lism disturbances were diagnosed (in or-
der of frequency; number and %): IFG 
39 (37,50%); IFG + IGT 22 (25,00%); 
T2DM 16 (18.18%); normal result of 
OGTT 11 (12,50%) and IGT 6 (6,82%). 
3. In general practice, emphasis on detection of 
glucose metabolism abnormalities allows ear-
ly diagnosis of medical problem in individual 
patients and implementation of lifestyle mo-
dification and/or pharmacological treatment.
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